T1	HMM 0 19	Efficacy and safety
T2	HMM 515 531	disease response
T3	HMM 551 565	response rates
T4	HMM 848 935	the overall response rate [complete clinical response (CCR) plus partial response (PR)]
T5	HMM 1157 1158	.
T6	HMM 1159 1174	Total UVA doses
T7	HMM 1291 1295	arm.
T8	HMM 1296 1314	The safety profile
T9	HMM 1330 1359	with few grade 3-4 toxicities
T10	HMM 1382 1383	.
T11	HMM 1384 1414	More drop-outs due to toxicity
T12	HMM 1486 1522	The best overall response (CCR + PR)
T13	HMM 1588 1595	0·57).
T14	HMM 1596 1627	The median duration of response
T15	HMM 1696 1704	= 0·33)
T16	HMM 1754 1764	PUVA alone
T17	HMM 1791 1810	combination therapy
T18	HMM 1821 1832	(P = 0·45)
T19	HMM 1920 1957	fewer PUVA sessions needed to achieve
T20	HMM 2079 2105	lower UVA dose required to
T21	HMM 2265 2316	significant difference in response rate or response
T22	HMM 2375 2436	trend towards fewer PUVA sessions and lower UVA dose required
